Acquisition History / Takara Holdings Inc. / Takara Bio Inc.
Takara Holdings Inc. Acquires Takara Bio Inc.
Announced February 16, 2026 — $244.5M
What happened
Takara Holdings tendered for its listed subsidiary Takara Bio, a supplier of research reagents and gene therapy services, from 16 February 2026 to take full ownership. The offer completed on 7 April 2026 for JPY 36.493bn.
- Acquirer
- Takara Holdings Inc.
- Target
- Takara Bio Inc.
- Announced
- February 16, 2026
- Price
- $244.5M
- Industry
- Biotechnology reagents and gene therapy
- Buyer type
- Strategic acquirer
- Status
- Closed
By the numbers
Frequently Asked Questions About This Acquisition
When did Takara Holdings Inc. acquire Takara Bio Inc.?
Takara Holdings Inc. acquired Takara Bio Inc. on February 16, 2026. This was Takara Holdings Inc.'s 1st publicly tracked acquisition out of 1 we have on record.
How much did Takara Holdings Inc. pay for Takara Bio Inc.?
Takara Holdings Inc. paid $244.5M for Takara Bio Inc..
What does Takara Bio Inc. do?
Takara Holdings tendered for its listed subsidiary Takara Bio, a supplier of research reagents and gene therapy services, from 16 February 2026 to take full ownership. The offer completed on 7 April 2026 for JPY 36.493bn.
What other Biotechnology reagents and gene therapy companies has Takara Holdings Inc. acquired?
Takara Bio Inc. is Takara Holdings Inc.'s only publicly tracked acquisition in Biotechnology reagents and gene therapy so far.